Under the terms of the partnership, Abbott will utilise its distribution infrastructure to promote MSD’s sitagliptin-based products — Januvia, Janumet, and Janumet XR. Shares of Abbott India dropped ₹293.35 (-0.92%), ending the day at ₹31,510 on the BSE today (June 18).
